STAT January 14, 2026
Allison DeAngelis, Adam Feuerstein, Elaine Chen

How did an office clerk become CEO of a major pharmaceutical company? What’s “Project Prometheus”? And what’s next in drug R&D?

Allison, Adam, and Elaine are asking those questions live from the J.P. Morgan Healthcare Conference in San Francisco.

Then, ARCH Venture Partners co-founder and managing director Bob Nelsen takes the mic to discuss everything going on in D.C., China’s ascent in biomedical innovation, and the use of AI in biotech.

New Novo Nordisk CEO Mike Doustdar joins the podcast hosts live to discuss...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

Continue Reading

 
Topics: Biotechnology, Conferences / Podcast, Pharma / Biotech, Trends
Related Articles:
Data Visualization is Broken in Biotech: Q&A with Sunitha Venkat
Biotech investor Cormorant secures $150M for another SPAC deal
The Future of Pharmacovigilance Technology: How AI and Automation Are Redefining Drug Safety
Introducing the Sunday Times Tech 100: Life sciences part 1
China’s edge in early-stage drugmaking ‘likely to persist,’ Pitchbook says

Share Article